OPS-2071 Single and Multiple Dose Study to Investigate PK and PD Profile in Healthy Korean Male Subjects.

NCT01925521 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Part1 : OPS-2071
DRUG: Part1 : Placebo of OPS-2071
DRUG: Part2 : OPS-2071
DRUG: Part2 : Placebo of OPS-2071

Sponsor

Korea Otsuka Pharmaceutical Co., Ltd.

Collaborators

[object Object]